Brazilian Association of Thalassemia protocol for iron chelation therapy in patients under regular transfusion

Abstract

In the absence of an iron chelating agent, patients with beta-thalassemia on regular transfusions present complications of transfusion-related iron overload. Without iron chelation therapy, heart disease is the major cause of death; however, hepatic and endocrine complications also occur. Currently there are three iron chelating agents available for continuous use in patients with thalassemia on regular transfusions (desferrioxamine, deferiprone, and deferasirox) providing good results in reducing cardiac, hepatic and endocrine toxicity. These practice guidelines, prepared by the Scientific Committee of Associação Brasileira de Thalassemia (ABRASTA), presents a review of the literature regarding iron overload assessment (by imaging and laboratory exams) and the role of T2* magnetic resonance imaging (MRI) to control iron overload and iron chelation therapy, with evidence-based recommendations for each clinical situation. Based on this review, the authors propose an iron chelation protocol for patients with thalassemia under regular transfusions.

Role of vitamin C as an adjuvant therapy to different iron chelators in young β‐thalassemia major patients: efficacy and safety in relation to tissue iron overload

“…P3: baseline vs. post-therapy among DFO group. 1 Mean SF was calculated for each patient during the last year prior to the study.…”

Talassemia beta maior e gestação na adolescência: relato de dois casos

“…A triagem de distúrbios endocrinológicos e de cardiopatias foi realizada em ambas as pacientes, conforme importância mostrada em literatura 2,5,20,21 , sendo excluídos o diabetes gestacional (no segundo e terceiro trimestres) e cardiopatias (com avaliação por cardiologista e ecocardiografia normal).…”

Gambaran eGFR Menurut CKD-EPI pada Penderita Thalassemia Mayor di Rumah Sakit Dr. Hasan Sadikin Bandung

“…Deferipone oral dikatakan cukup aman untuk ginjal. 1,14 Penyebab pasti mekanisme kerusakan ginjal akibat pemakaian kelasi besi masih belum diketahui dan membutuhkan penelitian lebih lanjut. 1 Pada pemakaian deferasirox, diduga penyebab peningkatan kreatinin secara reversibel akibat efek farmakologik deferasirox terhadap intraglomerular hemodinamik ginjal.…”

“…9 Pemakaian desferrioxamine dosis tinggi dapat menyebabkan perubahan fungsi ginjal dan pemakaian deferiprone dilaporkan relatif aman untuk ginjal. 1,14 Terjadinya gangguan ginjal pada penderita thalassemia memerlukan pengawasan fungsi ginjal yang rutin. Walaupun tidak ada bukti kuat untuk menentukan kapan sebaiknya dilakukan pemeriksaan fungsi ginjal, tetapi pengukuran fungsi ginjal dianjurkan…”